Abstract
Cytosolic proteins containing SH2 and SH3 domains, such as Crk and Crk-like (CrkL), are broadly expressed adapters that interact with a variety of proteins to fulfill key roles in signal transduction pathways triggered by activation of receptor and non-receptor tyrosine kinases. Crk and CrkL are similar to each other in structure and biochemical function, although they provide both distinct, as well as overlapping, biological roles during development. We developed a systematic approach to investigate Crk family functions at the cellular level by generating a conditional knock-out system for ablation of Crk and CrkL in cultured fibroblasts. The loss of both Crk and CrkL from fibroblasts resulted in reduced cell surface area and adoption of a rounded, refractile cellular phenotype. These morphological alterations were accompanied by a decrease in focal adhesion sites, reduced actin stress fibers and a collapse of microtubule structures. In addition, cells exhibited decreases in spontaneous motility and wound-healing behavior. Reduced p130Cas phosphorylation and actin levels closely followed the loss of Crk and CrkL, and stabilization of polymerized actin by jasplakinolide suppressed the morphological conversion. Ablation of Crk or CrkL alone conferred a much more modest phenotype suggesting that Crk and CrkL have overlapping functions that are critical for maintaining cell structure. The morphological alterations could be partially rescued by reintroduction of CrkII, and, to a lesser extent, CrkL. Taken together, our results suggest that Crk and CrkL have critical roles in cell structure and motility by maintaining cytoskeletal integrity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Birge RB, Kalodimos C, Inagaki F, Tanaka S . Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal 2009; 7: 13.
Reichman CT, Mayer BJ, Keshav S, Hanafusa H . The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ 1992; 3: 451–460.
Mayer BJ, Hamaguchi M, Hanafusa H . A novel viral oncogene with structural similarity to phospholipase C. Nature 1988; 332: 272–275.
Feller SM . Crk family adaptors-signalling complex formation and biological roles. Oncogene 2001; 20: 6348–6371.
Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M . Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 1992; 12: 3482–3489.
Senechal K, Halpern J, Sawyers CL . The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene. J Biol Chem 1996; 271: 23255–23261.
Sriram G, Birge RB . Emerging roles for crk in human cancer. Genes Cancer 2010; 1: 1132–1139.
Rodrigues SP, Fathers KE, Chan G, Zuo D, Halwani F, Meterissian S et al. CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Mol Cancer Res 2005; 3: 183–194.
Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE et al. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 2003; 22: 7950–7957.
Nishihara H, Tanaka S, Tsuda M, Oikawa S, Maeda M, Shimizu M et al. Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett 2002; 180: 55–61.
Linghu H, Tsuda M, Makino Y, Sakai M, Watanabe T, Ichihara S et al. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 2006; 25: 3547–3556.
Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A et al. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Mol Cancer Res 2006; 4: 499–510.
Kim YH, Kwei KA, Girard L, Salari K, Kao J, Pacyna-Gengelbach M et al. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer. Oncogene 2010; 29: 1421–1430.
Park TJ, Boyd K, Curran T . Cardiovascular and craniofacial defects in Crk-null mice. Mol Cell Biol 2006; 26: 6272–6282.
Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A . Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 2001; 27: 293–298.
Park TJ, Curran T . Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway. J Neurosci 2008; 28: 13551–13562.
Hallock PT, Xu CF, Park TJ, Neubert TA, Curran T, Burden SJ . Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L. Genes Dev 2010; 24: 2451–2461.
Birge RB, Fajardo JE, Reichman C, Shoelson SE, Songyang Z, Cantley LC et al. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol Cell Biol 1993; 13: 4648–4656.
Polte TR, Hanks SK . Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. Proc Natl Acad Sci USA 1995; 92: 10678–10682.
Salgia R, Uemura N, Okuda K, Li JL, Pisick E, Sattler M et al. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J Biol Chem 1995; 270: 29145–29150.
Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004; 113: 115–123.
Kong JY, Rabkin SW . Cytoskeletal actin degradation induced by lovastatin in cardiomyocytes is mediated through caspase-2. Cell Biol Int 2004; 28: 781–790.
Mashima T, Naito M, Tsuruo T . Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 1999; 18: 2423–2430.
Tikhmyanova N, Little JL, Golemis EA . CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 2010; 67: 1025–1048.
Antoku S, Mayer BJ . Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals. J Cell Sci 2009; 122 (Pt 22): 4228–4238.
George B, Verma R, Soofi AA, Garg P, Zhang J, Park TJ et al. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J Clin Invest 2012; 122: 674–692.
Fathers KE, Bell ES, Rajadurai CV, Cory S, Zhao H, Mourskaia A et al. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis. Breast Cancer Res 2012; 14: R74.
Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y et al. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol 2007; 14: 503–510.
Sarkar P, Reichman C, Saleh T, Birge RB, Kalodimos CG . Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol Cell 2007; 25: 413–426.
Matsuda M, Mayer BJ, Fukui Y, Hanafusa H . Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 1990; 248: 1537–1539.
Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H et al. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 1994; 13: 3748–3756.
Honda H, Oda H, Nakamoto T, Honda Z, Sakai R, Suzuki T et al. Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 1998; 19: 361–365.
Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE et al. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 2002; 22: 901–915.
Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377: 539–544.
Shishido T, Akagi T, Chalmers A, Maeda M, Terada T, Georgescu MM et al. Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 2001; 6: 431–440.
Acknowledgements
We thank Hanna Li and Erin Finn for their technical assistance and Mateusz Koptyra for critical reading of the manuscript. This work was supported by a Pennsylvania Department of Health Cure Formulary grant (SAP#4100047628 to TC).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Park, TJ., Curran, T. Essential roles of Crk and CrkL in fibroblast structure and motility. Oncogene 33, 5121–5132 (2014). https://doi.org/10.1038/onc.2013.453
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2013.453
Keywords
This article is cited by
-
Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation
Angiogenesis (2021)
-
Fibroblast growth factor signalling in osteoarthritis and cartilage repair
Nature Reviews Rheumatology (2020)